A dietary supplement used to build muscle – or prevent muscle loss as a result of ageing or illness – is to be trialled as a potential treatment for chronic liver disease.
"Patients with MASH-related cirrhosis have extremely limited treatment options ... had similar characteristics such as severity of liver disease at their baseline liver biopsy.
Key Takeaways Akero Therapeutics shares traded near their all-time high as the drugmaker reported positive results in a study of its treatment for liver disease.The drug, known as EFX, helped reverse ...